Skip to ContentSkip to Navigation
Over ons Praktische zaken Waar vindt u ons prof. dr. E.M.D. (Ed) Schuuring

Publicaties

A scenario-drafting study to explore potential future implementation pathways of circulating tumor DNA testing in oncology

Critical Factors in the Analytical Work Flow of Circulating Tumor DNA-Based Molecular Profiling

Developments in predictive biomarker testing and targeted therapy in advanced stage non-small cell lung cancer and their application across European countries

Future perspective for the application of predictive biomarker testing in advanced stage non-small cell lung cancer

Levels of circulating tumor DNA correlate with tumor volume in gastro-intestinal stromal tumors: an exploratory long-term follow-up study

Methylation Analysis to Detect CIN3+ in High-Risk Human Papillomavirus-Positive Self-Samples From the Population-Based Cervical Cancer Screening Program

Regional differences in predictive biomarker testing rates for patients with metastatic NSCLC in the Netherlands

95P Automatic data processing to identify EGFR mutations in pathology reports of patients with non-small cell lung cancer (NSCLC)

A Micro-Costing Framework for Circulating Tumor DNA Testing in Dutch Clinical Practice

A novel PPP2R2A::PRKD1 fusion in a cribriform adenocarcinoma of salivary gland

Lees meer

Pers/media

Doelgerichte therapie bij longkanker

Naar een heel nieuw systeem voor kankerzorg en -diagnostiek

Commissie Beoordeling Diagnostiek

Organisatie moleculaire diagnostiek bij mammacarcinoom

At ESMO, Focusing on Non-Small Cell Lung Cancer

Longkanker: welke vorm heb ik?

25 jaar Moleculaire Diagnostiek binnen de Pathologie in Nederland

Moleculaire diagnostiek volop in beweging

“Betere diagnostiek verhoogt overlevingskans”

Lees meer